Lymphomatoid granulomatosis (LYG) is a rare angiodestructive lymphoproliferative disorder (LPD) of uncertain etiology, with prominent pulmonary involvement. Recent studies indicate that LYG is an EpsteinBarr virus (EBV)-associated B cell LPD with large numbers of background reactive T lymphocytes (T cell-rich B cell lymphoma). Although the disease frequently, but not exclusively, occurs in various immunodeficiency states, it has not been reported in association with the transient immunosuppression following autologous bone marrow/peripheral stem cell transplantation (ABM/PSCT). We describe a patient who developed lymphomatoid granulomatosis of the lung approximately 2 weeks after high-dose chemotherapy and autologous peripheral stem cell transplantation for multiple myeloma. Although molecular studies showed no evidence of EBV genome in the biopsy material, the serologic profile with high IgM titers was suggestive of primary EBV infection. Complete radiologic remission occurred following reconstitution of the patient's immune response after a 2-week course of ganciclovir treatment. Despite the apparently low frequency of LPD (both LYG and EBV-associated post-transplant lymphoma) in the ABMT setting, we believe that it should be considered in the differential diagnosis of patients whose clinical course following ABMT is complicated by fevers, in the absence of an identifiable infectious process. Keywords: EBV; lymphomatoid granulomatosis; autologous transplantation; immunosuppression Lymphomatoid granulomatosis, initially described by Liebow in 1972, is characterized histologically by a polymorphic lymphoid infiltrate with varying degrees of necrosis Correspondence: Dr G Tricot, Marlene and Stewart Greenebaum Cancer Center, University of Maryland Medicine, 22 S Greene Street, Baltimore, MD 21201, USA 2 Dr Fassas' current address is also the Marlene and Stewart Greenebaum Cancer Center Received 27 May 1998; accepted 3 August 1998 and vasculitis. Despite initial controversy regarding the lineage, nature, and even terminology of the disease, there is now general agreement that LYG should be classified as a lymphoproliferative disorder in which cytologically atypical, large B cells are scattered in a background of reactive, nonneoplastic T lymphocytes. Double-labeling studies using immunohistochemistry and in situ hybridization have confirmed the presence of EBV sequences within the B cells only and absence of EBV from the surrounding, more numerous T cells.
and vasculitis. Despite initial controversy regarding the lineage, nature, and even terminology of the disease, there is now general agreement that LYG should be classified as a lymphoproliferative disorder in which cytologically atypical, large B cells are scattered in a background of reactive, nonneoplastic T lymphocytes. Double-labeling studies using immunohistochemistry and in situ hybridization have confirmed the presence of EBV sequences within the B cells only and absence of EBV from the surrounding, more numerous T cells. 1, 2 Although most cases occur sporadically in otherwise immunocompetent patients, there are many reports of LYG complicating various acquired and congenital immunodeficiency states, such as solid organ transplantation, 3 HIV infection/AIDS, 4 X-linked lymphoproliferative syndrome 5 and Wiscott-Aldrich syndrome. 6 A patient who developed lymphomatoid granulomatosis, possibly associated with primary EBV infection, following autologous peripheral blood stem cell transplantation for multiple myeloma is reported here.
Case report
A 60-year-old woman was diagnosed with stage IIIA IgG kappa multiple myeloma in May 1995. After radiation treatment to a large plasmacytoma of the left ischium, she received three courses of VAD (vincristine, adriamycin, dexamethasone) chemotherapy. Following peripheral blood stem cell (PBSC) mobilization with high-dose cyclophosphamide (6 g/m 2 ), she received melphalan (200 mg/m 2 ) followed by autologous PBSC transplantation, in January 1996. Neutropenic fever and cough without dyspnea developed on post-transplant day 7 (day +7). Physical examination was significant for mild mucositis and rales at the right lung base. No organomegaly or lymphadenopathy were detected. Chest radiographs revealed a right middle lobe nodular infiltrate. Because of persistent fever, despite broad-spectrum antibiotics and neutrophil recovery (Ͼ1 × 10 9 /l achieved on day +9), she underwent bronchoscopy on day +11. Bronchoalveolar lavage showed no growth of bacterial, fungal or acid-fast pathogens. The patient defervesced and remained relatively asymptomatic. An open biopsy was performed on day +17 because of rapid worsening of the right lung infiltrates on high resolution chest computed tomographic scan ( Figure 1A ). Histologic examination was diagnostic for lymphomatoid granulomatosis ( Figure 2 ). The patient's serum was positive for IgG and IgM antibodies to the EBV capsid antigen and IgG antibodies to the nuclear antigen (anti-VCA-IgG, anti-VCA IgM, anti-EBNA-IgG, respectively), a recent conversion from her negative, pre-transplant EBV serologic profile (December 1995). The serology was confirmed by an outside laboratory (Mayo Clinic). The absolute number of CD4 + T cells was 134/l. Ganciclovir at 5 mg/kg every 12 h was instituted on day +23, for a total of 14 days as well as low-dose GM-CSF (25 g/day subcutaneously). Serial computed tomographic scans of the chest documented initially partial regression and finally complete resolution ( Figure 1B 
Pathology
Histologic examination revealed nodular angiocentric polymorphous lymphoid infiltrates (Figure 2A) , in which atypical large lymphoid cells with prominent nucleoli were scattered throughout a mixed population of reactive lymphocytes, histiocytes and occasional plasma cells ( Figure 2B ). The atypical large cells were CD20 positive by immunostaining ( Figure 2C ), but negative for CD43 and CD45RO. No organisms or cytopathic inclusions were detected on frozen section. Cultures of the biopsied specimen were negative for bacterial, fungal or acid-fast pathogens. In situ hybridization with the EBER RNA probe was negative.
Discussion
This is the first report, to the best of our knowledge, of a patient who developed LYG in association with an autotransplant. Lung involvement (the most frequent manifestation of LYG) was detected in association with fever and serologic evidence of acute EBV infection approximately 15 days after PBSC transplantation.
The failure, in our case, to detect the EBV genome may be due to technical problems but is more likely due to the scarcity of neoplastic B cells in the specimen analysed. This same problem of atypical cells might explain the failure of several studies to identify IgH gene rearrangements in patients with LYG. 7 Furthermore, the number of EBV +B cells/high power field has been found to correlate with histologic grade and, more importantly, outcome. 8 The favorable outcome in our patient may partly reflect her lower disease 'burden'. Although the sensitivity and specificity of detection of anti-VCA-IgM in immunosuppressed patients have been unclear in the literature, it is possible that the patient developed primary EBV infection. If anything, the inability of patients with underlying immunodeficiency to mount an EBV immune response might lead to an underestimation of the incidence of primary infection.
Occurrence of LYG in immunodeficient patients and its association with EBV infection of B cells just like the posttransplant LPD (PTLPD) suggests a relationship between these two entities. Based on serologic evidence and the occasional success of antivirals in treating PTLPD, we chose to give our patient ganciclovir. It is unclear if the patient's response was due to the effect of ganciclovir (especially in the case of polyclonal EBV infection, which cannot be ruled out in this case), or just simply to restoration of her immune function.
Post-transplant EBV-associated LPDs is a well recognized complication of allogeneic bone marrow transplantation, especially in HLA-mismatched and T cell-depleted marrow grafts. On the contrary, only three reports describing four patients who developed EBV-related LPDs after ABMT have been found in the English literature. [9] [10] [11] All patients developed the lymphoma 1-2 months following ABMT. Three of them presented with fevers. Monoclonal EBV infection was documented in three patients. One patient (with the polyclonal lymphoma) survived treatment with steroids, alpha-interferon and acyclovir. Two patients died within 2-3 weeks following the diagnosis of lymphoma. The clinical presentation or outcome of the fourth patient was not reported.
Despite the increasing number of autologous bone marrow/stem cell transplants performed for an ever expanding list of indications, it appears that LPDs (both LYG and EBV-lymphoma) rarely complicate procedure, probably because of the short duration of immunosuppression in these patients. However, the diagnosis should be considered especially when a clear infectious etiology for persistent fevers cannot be identified and patients have very low CD4 counts.
